Esophageal adenocarcinoma · 4 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
FLOT Variant #02 | — | R 3 835 | 14d | — | 50.0 mo | 9 | R 34 517 PFS proxy | 2 |
ECX Variant #01 | — | R 2 632 | 21d | — | 30.6 mo | 3 | R 7 896 PFS proxy | 3 |
ECF Variant #01 | — | R 2 442 | 21d | — | 35.0 mo | 9 | R 21 982 PFS proxy | 2 |
Cisplatin and Fluorouracil (CF) Variant #01 | — | R 1 783 | 28d | — | 23.4 mo | 3 | R 5 350 PFS proxy | 2 |
4 of 4 regimens shown